Related Experiment Video
Updated: May 10, 2026
06:41
A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis
Published on: March 9, 2015
Cytokine pathways and interactions in alopecia areata
Cerrene N Giordano1, Animesh A Sinha1
1Department of Dermatology University at Buffalo and Roswell Park Cancer Institute Rm. 6082, Clinical and Translational Research Center 845 Ellicott St, Buffalo, NY 14203, USA.
European Journal of Dermatology : EJD
|June 26, 2013
Summary
Alopecia areata (AA) is an autoimmune skin disease causing patchy hair loss. This review explores T cell and cytokine interactions in AA, highlighting research gaps for new treatments.
Area of Science:
- Immunology
- Dermatology
- Autoimmune Diseases
Background:
- Alopecia areata (AA) is an autoimmune condition characterized by non-scarring hair loss.
- T cell infiltrates and cytokine variations suggest immune system involvement in AA pathogenesis.
- Existing research points to TH1 and TH17 pathways, but a comprehensive view is missing.
Purpose of the Study:
- To critically review the literature on T cell-cytokine interactions in alopecia areata.
- To provide a framework for understanding the complex immune response in AA.
- To identify research areas for developing targeted therapies.
Main Methods:
- Comprehensive literature review of existing studies on AA.
- Analysis of T cell and cytokine involvement in disease etiopathogenesis.
- Synthesis of current knowledge to identify research gaps.
Main Results:
- T cell activation and inflammatory mediators are key in AA.
- TH1-mediated immunity is dominant, with potential TH17 pathway involvement.
- A complete understanding of intersecting cytokine networks is lacking.
Conclusions:
- Further research into T cell-cytokine networks is crucial for understanding AA.
- A precise understanding of cytokine pathways is needed for effective treatment strategies.
- Identifying specific cytokine targets may lead to novel therapeutic options for alopecia areata.
Related Concept Videos
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...